Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom.

Allergy Asthma Clin Immunol · 2013 · PMC3846485 · PMID 24004607

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Tendencies towards an increased risk of relapse in patients reporting repetitive field stings after initiation of VIT ( P = 0.07) or patients receiving honey bee VIT compared to those receiving Vespula VIT ( P = 0.50) did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.